Search research articles
Contact Us
Filters
Showing results (191-200 of 344) with videos related to
Page
of 35
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
October 15, 2016
P53 expression correlates with poorer survival and augments the negative prognostic effect of MYC rearrangement, expression or concurrent MYC/BCL2 expression in diffuse large B-cell lymphoma
Xuan J Wang, L Jeffrey Medeiros, Carlos E Bueso-Ramos, et al.
Experimental Hematology & Oncology
|
August 1, 2024
1q jumping translocation as a biomarker in myeloid malignancy: frequently mutated genes associated with bad prognosis and low survival
Eitan Halper-Stromberg, Victoria Stinnett, Laura Morsberger, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
August 7, 2019
PD-L1 expression is associated with ALK positivity and STAT3 activation, but not outcome in patients with systemic anaplastic large cell lymphoma
Jing Shen, Shaoying Li, L Jeffrey Medeiros, et al.
American Journal of Clinical Pathology
|
September 8, 2024
Flow cytometric immunophenotypic features of acute myeloid leukemia with mast cell differentiation
Jie Xu, Do Hwan Kim, Wei Wang, et al.
European Journal of Haematology
|
January 17, 2020
MYC rearrangement and MYC/BCL2 double expression but not cell-of-origin predict prognosis in R-CHOP treated diffuse large B-cell lymphoma
Jie Xu, Jing-Lan Liu, L Jeffrey Medeiros, et al.
Cancer
|
October 23, 2025
A tour of leukemia progress in 2025, viewed through the MD Anderson leukemia research lens
Hagop M Kantarjian, Gautam Borthakur, Naval Daver, et al.
American Journal of Hematology
|
March 5, 2024
Myeloid neoplasm with <10% blasts and t(3;5)(q25.1;q34)/NPM::MLF1: A classification dilemma
Fnu Sameeta, Hong Fang, Wei Wang, et al.
Cancers
|
December 9, 2023
Cytogenetic Profile in Monoclonal Gammopathy of Undetermined Significance, Smoldering and Symptomatic Multiple Myeloma: A Study of 1087 Patients with Highly Purified Plasma Cells
Guilin Tang, Yilin Wu, Pei Lin, et al.
Oncotarget
|
March 16, 2018
Acute myeloid leukemia with t(4;12)(q12;p13): an aggressive disease with frequent involvement of <i>PDGFRA</i> and <i>ETV6</i>
Jingyi Li, Jie Xu, Lynne V Abruzzo, et al.
Clinical Breast Cancer
|
March 6, 2023
Breast Cancer With a HER2 FISH Group 2 Result: Should HER2 Tests be Repeated?
Minhua Wang, Qingqing Ding, Jun Gu, et al.
Page
of 35
Search research articles
Search
Showing results (191-200 of 344) with videos related to
Sort By:
Page
of 35
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
October 15, 2016
P53 expression correlates with poorer survival and augments the negative prognostic effect of MYC rearrangement, expression or concurrent MYC/BCL2 expression in diffuse large B-cell lymphoma
Xuan J Wang, L Jeffrey Medeiros, Carlos E Bueso-Ramos, et al.
Experimental Hematology & Oncology
|
August 1, 2024
1q jumping translocation as a biomarker in myeloid malignancy: frequently mutated genes associated with bad prognosis and low survival
Eitan Halper-Stromberg, Victoria Stinnett, Laura Morsberger, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
August 7, 2019
PD-L1 expression is associated with ALK positivity and STAT3 activation, but not outcome in patients with systemic anaplastic large cell lymphoma
Jing Shen, Shaoying Li, L Jeffrey Medeiros, et al.
American Journal of Clinical Pathology
|
September 8, 2024
Flow cytometric immunophenotypic features of acute myeloid leukemia with mast cell differentiation
Jie Xu, Do Hwan Kim, Wei Wang, et al.
European Journal of Haematology
|
January 17, 2020
MYC rearrangement and MYC/BCL2 double expression but not cell-of-origin predict prognosis in R-CHOP treated diffuse large B-cell lymphoma
Jie Xu, Jing-Lan Liu, L Jeffrey Medeiros, et al.
Cancer
|
October 23, 2025
A tour of leukemia progress in 2025, viewed through the MD Anderson leukemia research lens
Hagop M Kantarjian, Gautam Borthakur, Naval Daver, et al.
American Journal of Hematology
|
March 5, 2024
Myeloid neoplasm with <10% blasts and t(3;5)(q25.1;q34)/NPM::MLF1: A classification dilemma
Fnu Sameeta, Hong Fang, Wei Wang, et al.
Cancers
|
December 9, 2023
Cytogenetic Profile in Monoclonal Gammopathy of Undetermined Significance, Smoldering and Symptomatic Multiple Myeloma: A Study of 1087 Patients with Highly Purified Plasma Cells
Guilin Tang, Yilin Wu, Pei Lin, et al.
Oncotarget
|
March 16, 2018
Acute myeloid leukemia with t(4;12)(q12;p13): an aggressive disease with frequent involvement of <i>PDGFRA</i> and <i>ETV6</i>
Jingyi Li, Jie Xu, Lynne V Abruzzo, et al.
Clinical Breast Cancer
|
March 6, 2023
Breast Cancer With a HER2 FISH Group 2 Result: Should HER2 Tests be Repeated?
Minhua Wang, Qingqing Ding, Jun Gu, et al.
Page
of 35